Napean Trading & Investment CO (Singapore) Pte LTD Charles River Laboratories International, Inc. Transaction History
Napean Trading & Investment CO (Singapore) Pte LTD
- $420 Billion
- Q2 2024
A detailed history of Napean Trading & Investment CO (Singapore) Pte LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Napean Trading & Investment CO (Singapore) Pte LTD holds 10,275 shares of CRL stock, worth $2.08 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
10,275
Previous 10,275
-0.0%
Holding current value
$2.08 Million
Previous $2.78 Billion
23.76%
% of portfolio
0.5%
Previous 0.68%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
733Shares Held
51.9MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.03 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$423 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$387 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$277 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...